Literature DB >> 10913340

Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22.

H Kirikoshi1, N Sagara, T Saitoh, K Tanaka, H Sekihara, K Shiokawa, M Katoh.   

Abstract

The fibroblast growth factors (FGFs) play important roles in morphogenesis, angiogenesis, tissue remodeling, and carcinogenesis. Human FGF-20 has been cloned and characterized in this study. FGF-20 encodes a 211-amino-acid polypeptide with the FGF-core domain. A strong hydrophobic region was found in the FGF-core domain of FGF-20; however, no typical N-terminal signal sequence was found in FGF-20, just as in FGF-9 and FGF-16. Total amino acid identities are as follows: FGF-20 vs FGF-9, 71.6%; FGF-20 vs FGF-16, 66.2%; FGF-9 vs FGF-16, 72.4%. Phylogenic analysis indicated that FGF-20, FGF-9, and FGF-16 constitute a subfamily among the FGF family. FGF-20 mRNA of 2.4 kb in size was detected in colon cancer cell line SW480 by Northern blot analysis. Lower levels of FGF-20 mRNA were detected in human fetal tissues and primary cancers by cDNA-PCR. The nucleotide sequence of FGF-20 cDNA is split into three parts in the human genome sequence of the chromosome 8p21.3-p22 region (Accession No. AB020858). These results indicate that the FGF-20 gene, located on human chromosome 8p21.3-p22, consists of three exons. Compared with the nucleotide sequence of FGF-20 cDNA determined in this study, one nucleotide deletion and one nucleotide substitution in the putative coding region were identified in human genome sequence AB020858. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913340     DOI: 10.1006/bbrc.2000.3142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFs.

Authors:  Sarah Tulin; Angelike Stathopoulos
Journal:  Birth Defects Res C Embryo Today       Date:  2010-09

2.  Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.

Authors:  Wei Quan; Jia Li; Li Liu; Qinghui Zhang; Yidan Qin; Xiaochen Pei; Jiajun Chen
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.830

3.  WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer.

Authors:  Hirohide Yoshikawa; Kenichi Matsubara; Xiaoling Zhou; Shu Okamura; Takahiko Kubo; Yaeko Murase; Yuko Shikauchi; Manel Esteller; James G Herman; Xin Wei Wang; Curtis C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

4.  Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.

Authors:  Xianjing Zhao; Yanfeng Wu; Can Zhao; Meijiang Feng
Journal:  Neurol Sci       Date:  2016-03-29       Impact factor: 3.307

5.  Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

Authors:  Joelle M van der Walt; Maher A Noureddine; Raja Kittappa; Michael A Hauser; William K Scott; Ron McKay; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

6.  Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.

Authors:  Ruixia Zhu; Ying Zhu; Xu Liu; Zhiyi He
Journal:  Neurol Sci       Date:  2014-06-19       Impact factor: 3.307

7.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

Review 8.  Fibroblast growth factors.

Authors:  D M Ornitz; N Itoh
Journal:  Genome Biol       Date:  2001-03-09       Impact factor: 13.583

9.  Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.

Authors:  Eugene L Boshoff; Edward J R Fletcher; Susan Duty
Journal:  Neuropharmacology       Date:  2018-04-23       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.